Fatal, gold-induced pneumonitis.
We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.
Soler
M Jose
MJ
Servicio de Neumologia, Hospital General Universitario, Alicante, Spain.
Barroso
Encarnacion
E
Aranda
F Ignacio
FI
Alonso
Sergio
S
Romero
Santiago
S
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D017809:Fatal Outcome; D005260:Female; D006052:Gold Sodium Thiomalate / Q000009:adverse effects*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*
D018501:Antirheumatic Agents; D006052:Gold Sodium Thiomalate